BIORESORBABLE SCAFFOLD FOR TREATMENT OF CORONARY ARTERY LESIONS: FINAL INTRAVASCULAR ULTRASOUND RESULTS FROM THE ABSORB JAPAN TRIAL

Methods In ABSORB JAPAN, serial (post-procedure (PP) and at 3 years (3Y)) IVUS was available in 128 lesions. %Device Expansion (%DE) was defined as mean device area / mean reference lumen area at PP. Lumen volume at 3Y did not differ significantly between the arms, while smaller %DE at PP significan...

Full description

Saved in:
Bibliographic Details
Published in:Journal of the American College of Cardiology 2018-03, Vol.71 (11), p.A1020-A1020
Main Authors: Okada, Kozo, Honda, Yasuhiro, Kitahara, Hideki, Ikutomi, Masayasu, Kameda, Ryo, Hollak, M. Brooke, Yock, Paul, Kusano, Hajime, Cheong, Wai-Fung, Sudhir, Krishnan, Fitzgerald, Peter, Kimura, Takeshi
Format: Article
Language:English
Subjects:
Biocompatibility
Biomedical materials
Cardiology
Coronary artery
Lesions
Stents
Surgical implants
Ultrasound
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Methods In ABSORB JAPAN, serial (post-procedure (PP) and at 3 years (3Y)) IVUS was available in 128 lesions. %Device Expansion (%DE) was defined as mean device area / mean reference lumen area at PP. Lumen volume at 3Y did not differ significantly between the arms, while smaller %DE at PP significantly correlated with greater late lumen loss (LLL) in Absorb BVS (r=0.36, p=0.004), which was primarily attributable to greater negative remodeling (r=0.25, p=0.08) rather than plaque/neointimal proliferation (p=0.46).
ISSN:0735-1097
1558-3597
DOI:10.1016/S0735-1097(18)31561-4